BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 25477176)

  • 1. Phosphorescent iridium(III)-bis-N-heterocyclic carbene complexes as mitochondria-targeted theranostic and photodynamic anticancer agents.
    Li Y; Tan CP; Zhang W; He L; Ji LN; Mao ZW
    Biomaterials; 2015 Jan; 39():95-104. PubMed ID: 25477176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclometalated iridium(iii) N-heterocyclic carbene complexes as potential mitochondrial anticancer and photodynamic agents.
    Li Y; Liu B; Lu XR; Li MF; Ji LN; Mao ZW
    Dalton Trans; 2017 Aug; 46(34):11363-11371. PubMed ID: 28812748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coumarin-appended phosphorescent cyclometalated iridium(iii) complexes as mitochondria-targeted theranostic anticancer agents.
    Ye RR; Tan CP; Ji LN; Mao ZW
    Dalton Trans; 2016 Aug; 45(33):13042-51. PubMed ID: 27139504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, photophysical and anticancer properties of mitochondria-targeted phosphorescent cyclometalated iridium(III) N-heterocyclic carbene complexes.
    Li Y; Wang KN; He L; Ji LN; Mao ZW
    J Inorg Biochem; 2020 Apr; 205():110976. PubMed ID: 31926377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel and Versatile Imine-N-Heterocyclic Carbene Half-Sandwich Iridium(III) Complexes as Lysosome-Targeted Anticancer Agents.
    Yang Y; Guo L; Tian Z; Gong Y; Zheng H; Zhang S; Xu Z; Ge X; Liu Z
    Inorg Chem; 2018 Sep; 57(17):11087-11098. PubMed ID: 30133276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lysosome-targeted chemotherapeutics: Anticancer mechanism of N-heterocyclic carbene iridium(III) complex.
    Zhang J; Liu J; Liu X; Liu B; Song S; He X; Che C; Si M; Yang G; Liu Z
    J Inorg Biochem; 2020 Jun; 207():111063. PubMed ID: 32222581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclometalated iridium(III)-guanidinium complexes as mitochondria-targeted anticancer agents.
    Song XD; Kong X; He SF; Chen JX; Sun J; Chen BB; Zhao JW; Mao ZW
    Eur J Med Chem; 2017 Sep; 138():246-254. PubMed ID: 28668477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondria-targeted phosphorescent cyclometalated iridium(III) complexes: synthesis, characterization, and anticancer properties.
    Li Y; Liu B; Xu CX; He L; Wan YC; Ji LN; Mao ZW
    J Biol Inorg Chem; 2020 Jun; 25(4):597-607. PubMed ID: 32232583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mixed-ligand iridium(iii) complexes as photodynamic anticancer agents.
    Zheng Y; He L; Zhang DY; Tan CP; Ji LN; Mao ZW
    Dalton Trans; 2017 Aug; 46(34):11395-11407. PubMed ID: 28813052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutral iridium(iii) complexes bearing BODIPY-substituted N-heterocyclic carbene (NHC) ligands: synthesis, photophysics, in vitro theranostic photodynamic therapy, and antimicrobial activity.
    Liu B; Monro S; Jabed MA; Cameron CG; Colón KL; Xu W; Kilina S; McFarland SA; Sun W
    Photochem Photobiol Sci; 2019 Oct; 18(10):2381-2396. PubMed ID: 31432864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Valproic Acid-Functionalized Cyclometalated Iridium(III) Complexes as Mitochondria-Targeting Anticancer Agents.
    Ye RR; Cao JJ; Tan CP; Ji LN; Mao ZW
    Chemistry; 2017 Oct; 23(60):15166-15176. PubMed ID: 28833658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thiabendazole-based Rh(III) and Ir(III) biscyclometallated complexes with mitochondria-targeted anticancer activity and metal-sensitive photodynamic activity.
    Pérez-Arnaiz C; Acuña MI; Busto N; Echevarría I; Martínez-Alonso M; Espino G; García B; Domínguez F
    Eur J Med Chem; 2018 Sep; 157():279-293. PubMed ID: 30099251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Guanidine-modified cyclometalated iridium(III) complexes for mitochondria-targeted imaging and photodynamic therapy.
    Song XD; Chen BB; He SF; Pan NL; Liao JX; Chen JX; Wang GH; Sun J
    Eur J Med Chem; 2019 Oct; 179():26-37. PubMed ID: 31233920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ester-Modified Cyclometalated Iridium(III) Complexes as Mitochondria-Targeting Anticancer Agents.
    Wang FX; Chen MH; Hu XY; Ye RR; Tan CP; Ji LN; Mao ZW
    Sci Rep; 2016 Dec; 6():38954. PubMed ID: 27958338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Iridium metal complexes containing N-heterocyclic carbene ligands for blue-light-emitting electrochemical cells.
    Yang CH; Beltran J; Lemaur V; Cornil J; Hartmann D; Sarfert W; Fröhlich R; Bizzarri C; De Cola L
    Inorg Chem; 2010 Nov; 49(21):9891-901. PubMed ID: 20932024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondria-targeting cyclometalated iridium(III)-PEG complexes with tunable photodynamic activity.
    Li SP; Lau CT; Louie MW; Lam YW; Cheng SH; Lo KK
    Biomaterials; 2013 Oct; 34(30):7519-32. PubMed ID: 23849346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Half-sandwich Iridium
    Han Y; Tian Z; Zhang S; Liu X; Li J; Li Y; Liu Y; Gao M; Liu Z
    J Inorg Biochem; 2018 Dec; 189():163-171. PubMed ID: 30268969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Photoinduced anticancer activity studies of iridium(III) complexes targeting mitochondria and tubules.
    Zhang WY; Yi QY; Wang YJ; Du F; He M; Tang B; Wan D; Liu YJ; Huang HL
    Eur J Med Chem; 2018 May; 151():568-584. PubMed ID: 29656200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclometalated Ir(III) complexes as targeted theranostic anticancer therapeutics: combining HDAC inhibition with photodynamic therapy.
    Ye RR; Tan CP; He L; Chen MH; Ji LN; Mao ZW
    Chem Commun (Camb); 2014 Sep; 50(75):10945-8. PubMed ID: 25096019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Membrane localized iridium(III) complex induces endoplasmic reticulum stress and mitochondria-mediated apoptosis in human cancer cells.
    Cao R; Jia J; Ma X; Zhou M; Fei H
    J Med Chem; 2013 May; 56(9):3636-44. PubMed ID: 23594206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.